murine macrophage cell line raw264 7 (ATCC)
Structured Review
Murine Macrophage Cell Line Raw264 7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 24281 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/murine+raw264+7+cell+line/RAW+264%2E7/pmc13059125-142-1-6
Average 99 stars, based on 24281 article reviews
Images
Related Articles
Potency Assay:Article Title: HC-HA/PTX3 from amniotic membrane reprograms human corneal fibroblasts to neural crest progenitors by switching from canonical to noncanonical TGFβ signaling Article Snippet: .. Finally, each batch of HC-HA/PTX3 was released after passing a potency assay by exhibiting no less than (NLT) 90% of inhibiting the tartrate-resistant acid phosphatase (TRAP) activity of osteoclast differentiation in cloned monocytes of Article Title: HC-HA/PTX3 from amniotic membrane reprograms human corneal fibroblasts to neural crest progenitors by switching from canonical to noncanonical TGFβ signaling. Article Snippet: .. Finally, each batch of HC-HA/PTX3 was released after passing a potency assay by exhibiting no less than (NLT) 90% of inhibiting the tartrate-resistant acid phosphatase (TRAP) ACCEPTED MANUSCRIPT AR TIC LE IN PR ES S ARTICLE IN PRESS activity of osteoclast differentiation in cloned monocytes of Article Title: HC-HA/PTX3 from amniotic membrane reprograms human corneal fibroblasts to neural crest progenitors by switching from canonical to noncanonical TGFβ signaling. Article Snippet: .. In addition, each batch of HC-HA/PTX3 was released after passing the potency assay with the acceptance criteria of no less than 89% inhibition of tartrate-resistant acid phosphatase (TRAP) activity of osteoclast differentiation in cloned monocytes of Article Title: Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain Article Snippet: It was released by confirming the identity of HC- HA/PTX3 based on Western blot analysis using respective antibody specific to HC1 (ITIH1 antibody, Cat# ab70048, Abcam, Waltham, MA, USA) and PTX3 (PTX3 antibody, Cat# ALX- 804- 464- C100, Enzo, Farmingdale, NY, USA) with or without hyaluronidase (HAase) digestion to release HC1 and HMW PTX3 from HC- HA/PTX3 in the loading well into the gel and with or without reduction by DTT, which further rendered PTX3 from HMW (octamer) to dimer and monomer (Figure 3—figure supplement 1C, D). .. In addition, each batch of HC- HA/PTX3 was released after it also passed the potency assay (Figure 3—figure supplement 1E), with the acceptance criterion of no less than 89.21% inhibition of tartrate- resistant acid phosphatase (TRAP) activity of osteoclast differentiation in cloned monocytes of Article Title: Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain Article Snippet: It was released by confirming the identity of HC-HA/PTX3 based on Western blot analysis using respective antibody specific to HC1 (ITIH1 antibody, Cat# ab70048, Abcam, Waltham, MA, USA) and PTX3 (PTX3 antibody, Cat# ALX-804-464-C100, Enzo, Farmingdale, NY, USA) with or without hyaluronidase (HAase) digestion to release HC1 and HMW PTX3 from HC-HA/PTX3 in the loading well into the gel and with or without reduction by DTT, which further rendered PTX3 from HMW (octamer) to dimer and monomer ( ). .. In addition, each batch of HC-HA/PTX3 was released after it also passed the potency assay , with the acceptance criterion of no less than 89.21% inhibition of tartrate-resistant acid phosphatase (TRAP) activity of osteoclast differentiation in cloned monocytes of Activity Assay:Article Title: HC-HA/PTX3 from amniotic membrane reprograms human corneal fibroblasts to neural crest progenitors by switching from canonical to noncanonical TGFβ signaling Article Snippet: .. Finally, each batch of HC-HA/PTX3 was released after passing a potency assay by exhibiting no less than (NLT) 90% of inhibiting the tartrate-resistant acid phosphatase (TRAP) activity of osteoclast differentiation in cloned monocytes of Article Title: HC-HA/PTX3 from amniotic membrane reprograms human corneal fibroblasts to neural crest progenitors by switching from canonical to noncanonical TGFβ signaling. Article Snippet: .. Finally, each batch of HC-HA/PTX3 was released after passing a potency assay by exhibiting no less than (NLT) 90% of inhibiting the tartrate-resistant acid phosphatase (TRAP) ACCEPTED MANUSCRIPT AR TIC LE IN PR ES S ARTICLE IN PRESS activity of osteoclast differentiation in cloned monocytes of Article Title: HC-HA/PTX3 from amniotic membrane reprograms human corneal fibroblasts to neural crest progenitors by switching from canonical to noncanonical TGFβ signaling. Article Snippet: .. In addition, each batch of HC-HA/PTX3 was released after passing the potency assay with the acceptance criteria of no less than 89% inhibition of tartrate-resistant acid phosphatase (TRAP) activity of osteoclast differentiation in cloned monocytes of Article Title: Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain Article Snippet: It was released by confirming the identity of HC- HA/PTX3 based on Western blot analysis using respective antibody specific to HC1 (ITIH1 antibody, Cat# ab70048, Abcam, Waltham, MA, USA) and PTX3 (PTX3 antibody, Cat# ALX- 804- 464- C100, Enzo, Farmingdale, NY, USA) with or without hyaluronidase (HAase) digestion to release HC1 and HMW PTX3 from HC- HA/PTX3 in the loading well into the gel and with or without reduction by DTT, which further rendered PTX3 from HMW (octamer) to dimer and monomer (Figure 3—figure supplement 1C, D). .. In addition, each batch of HC- HA/PTX3 was released after it also passed the potency assay (Figure 3—figure supplement 1E), with the acceptance criterion of no less than 89.21% inhibition of tartrate- resistant acid phosphatase (TRAP) activity of osteoclast differentiation in cloned monocytes of Article Title: Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain Article Snippet: It was released by confirming the identity of HC-HA/PTX3 based on Western blot analysis using respective antibody specific to HC1 (ITIH1 antibody, Cat# ab70048, Abcam, Waltham, MA, USA) and PTX3 (PTX3 antibody, Cat# ALX-804-464-C100, Enzo, Farmingdale, NY, USA) with or without hyaluronidase (HAase) digestion to release HC1 and HMW PTX3 from HC-HA/PTX3 in the loading well into the gel and with or without reduction by DTT, which further rendered PTX3 from HMW (octamer) to dimer and monomer ( ). .. In addition, each batch of HC-HA/PTX3 was released after it also passed the potency assay , with the acceptance criterion of no less than 89.21% inhibition of tartrate-resistant acid phosphatase (TRAP) activity of osteoclast differentiation in cloned monocytes of Clone Assay:Article Title: HC-HA/PTX3 from amniotic membrane reprograms human corneal fibroblasts to neural crest progenitors by switching from canonical to noncanonical TGFβ signaling Article Snippet: .. Finally, each batch of HC-HA/PTX3 was released after passing a potency assay by exhibiting no less than (NLT) 90% of inhibiting the tartrate-resistant acid phosphatase (TRAP) activity of osteoclast differentiation in cloned monocytes of Article Title: HC-HA/PTX3 from amniotic membrane reprograms human corneal fibroblasts to neural crest progenitors by switching from canonical to noncanonical TGFβ signaling. Article Snippet: .. Finally, each batch of HC-HA/PTX3 was released after passing a potency assay by exhibiting no less than (NLT) 90% of inhibiting the tartrate-resistant acid phosphatase (TRAP) ACCEPTED MANUSCRIPT AR TIC LE IN PR ES S ARTICLE IN PRESS activity of osteoclast differentiation in cloned monocytes of Article Title: HC-HA/PTX3 from amniotic membrane reprograms human corneal fibroblasts to neural crest progenitors by switching from canonical to noncanonical TGFβ signaling. Article Snippet: .. In addition, each batch of HC-HA/PTX3 was released after passing the potency assay with the acceptance criteria of no less than 89% inhibition of tartrate-resistant acid phosphatase (TRAP) activity of osteoclast differentiation in cloned monocytes of Article Title: Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain Article Snippet: It was released by confirming the identity of HC- HA/PTX3 based on Western blot analysis using respective antibody specific to HC1 (ITIH1 antibody, Cat# ab70048, Abcam, Waltham, MA, USA) and PTX3 (PTX3 antibody, Cat# ALX- 804- 464- C100, Enzo, Farmingdale, NY, USA) with or without hyaluronidase (HAase) digestion to release HC1 and HMW PTX3 from HC- HA/PTX3 in the loading well into the gel and with or without reduction by DTT, which further rendered PTX3 from HMW (octamer) to dimer and monomer (Figure 3—figure supplement 1C, D). .. In addition, each batch of HC- HA/PTX3 was released after it also passed the potency assay (Figure 3—figure supplement 1E), with the acceptance criterion of no less than 89.21% inhibition of tartrate- resistant acid phosphatase (TRAP) activity of osteoclast differentiation in cloned monocytes of Article Title: Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain Article Snippet: It was released by confirming the identity of HC-HA/PTX3 based on Western blot analysis using respective antibody specific to HC1 (ITIH1 antibody, Cat# ab70048, Abcam, Waltham, MA, USA) and PTX3 (PTX3 antibody, Cat# ALX-804-464-C100, Enzo, Farmingdale, NY, USA) with or without hyaluronidase (HAase) digestion to release HC1 and HMW PTX3 from HC-HA/PTX3 in the loading well into the gel and with or without reduction by DTT, which further rendered PTX3 from HMW (octamer) to dimer and monomer ( ). .. In addition, each batch of HC-HA/PTX3 was released after it also passed the potency assay , with the acceptance criterion of no less than 89.21% inhibition of tartrate-resistant acid phosphatase (TRAP) activity of osteoclast differentiation in cloned monocytes of Inhibition:Article Title: HC-HA/PTX3 from amniotic membrane reprograms human corneal fibroblasts to neural crest progenitors by switching from canonical to noncanonical TGFβ signaling. Article Snippet: .. In addition, each batch of HC-HA/PTX3 was released after passing the potency assay with the acceptance criteria of no less than 89% inhibition of tartrate-resistant acid phosphatase (TRAP) activity of osteoclast differentiation in cloned monocytes of Article Title: Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain Article Snippet: It was released by confirming the identity of HC- HA/PTX3 based on Western blot analysis using respective antibody specific to HC1 (ITIH1 antibody, Cat# ab70048, Abcam, Waltham, MA, USA) and PTX3 (PTX3 antibody, Cat# ALX- 804- 464- C100, Enzo, Farmingdale, NY, USA) with or without hyaluronidase (HAase) digestion to release HC1 and HMW PTX3 from HC- HA/PTX3 in the loading well into the gel and with or without reduction by DTT, which further rendered PTX3 from HMW (octamer) to dimer and monomer (Figure 3—figure supplement 1C, D). .. In addition, each batch of HC- HA/PTX3 was released after it also passed the potency assay (Figure 3—figure supplement 1E), with the acceptance criterion of no less than 89.21% inhibition of tartrate- resistant acid phosphatase (TRAP) activity of osteoclast differentiation in cloned monocytes of Article Title: Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain Article Snippet: It was released by confirming the identity of HC-HA/PTX3 based on Western blot analysis using respective antibody specific to HC1 (ITIH1 antibody, Cat# ab70048, Abcam, Waltham, MA, USA) and PTX3 (PTX3 antibody, Cat# ALX-804-464-C100, Enzo, Farmingdale, NY, USA) with or without hyaluronidase (HAase) digestion to release HC1 and HMW PTX3 from HC-HA/PTX3 in the loading well into the gel and with or without reduction by DTT, which further rendered PTX3 from HMW (octamer) to dimer and monomer ( ). .. In addition, each batch of HC-HA/PTX3 was released after it also passed the potency assay , with the acceptance criterion of no less than 89.21% inhibition of tartrate-resistant acid phosphatase (TRAP) activity of osteoclast differentiation in cloned monocytes of Cell Culture:Article Title: Precise Control of the in vivo Fate of Nanomicelles Efficiently Treats Advanced Rheumatoid Arthritis via EGFR/JNK/MMP9 Pathway Article Snippet: Fluorescence Spectra The fluorescence spectra of FRET micelles were measured using a fluorescence spectrometer (Lambda 365, PerkinElmer, USA) at an excitation wavelength of 640 nm with a slit width of 2 nm, integration time of 0.1 s, and increment of 0.5 nm. .. Emission spectra were collected from 500 to 900 nm. https://doi.org/10.2147/IJN.S511421 International Journal of Nanomedicine 2025:20 5356 Powered by TCPDF (www.tcpdf.org) Cell Culture and Treatments The |


